1912] General 563 



the therapeutic effects of radio-active substances such as radium, 

 mesothorium, radiothorium, etc., and their decomposition products. 

 It possesses laboratories for chemical, zoological and botanical re- 

 search, and a complete equipment for physical measurements. The 

 Institute has been founded solely by private enterprise, contributions 

 to the extent of $5,000 a year having been guaranteed by the Kaiser 

 Wilhelm Gesellschaft zur Förderung der Wissenschaften and by 

 two radium firms. The two industrial firms are also prepared to 

 furnish the necessary material and measuring apparatus. The Insti- 

 tute has not been established in a new building. It is installed in a 

 rented house in Luisenplatz, in the neighborhood of the Charite, 

 where it is connected with a polyclinic in which intemists, surgeons 

 and other interested specialists will have opportunity to treat patients 

 with radiation apparatus of various forms and strength, emanators 

 for inhalation in closed rooms, apparatus for drinking the emana- 

 tions, and other forms of application. The director of the Institute 

 is privy councilor Wilhelm His, whose representative is Dr. Gud- 

 zent. He is supported by a commission to which Professors Kraus, 

 Orth, Lesser, Hildebrand, Bier, Zuntz, Hertwig, Hahn and Marck- 

 wald have assured their Cooperation. Fifteen work places are pro- 

 vided in the laboratory, which are accessible to foreign physicians. 

 There are two assistants to the director of the institute. A perma- 

 nent physico-chemical collaborator has been secured. 



Journalistic. Nezv Bulletin. Eli Lilly and Co., of Indian- 

 apolis, have begun the publication of The Lilly Scientific Bulletin. 

 The first number was issued on April 16. " Upon request, the Lilly 

 Scientific Bulletin will be sent regularly to libraries and individuals 

 interested in the sciences related to medicine and pharmacy." 



A new Journal for chemotherapy. Few branches of medicine 

 have experienced a development as sudden, intensive and effective 

 as the new domain of chemotherapy associated so closely with the 

 name and efforts of Paul Ehrlich. With mushroom-like growth, 

 new principles in therapy and new procedures in diagnosis have 

 arisen, commanding attention in every land where modern scientific 

 medicine exerts its beneficent influence. The literature which the 

 new work and its exploitation has inspired in a period counted better 

 by months than years, now reaches enormous proportions. This has 



